William G. Rice - 18 Jan 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Chair, President & CEO, Director
Signature
/s/ Janet Clennett as attorney-in-fact for William G. Rice
Issuer symbol
APTOF
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 16:18:13 UTC
Previous filing
17 Dec 2021
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Employee Option Grant Award $0 +700,000 $0.000000 700,000 18 Jan 2022 Common Shares 700,000 $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent (50%) of the options vest on 1/18/2023; the remaining 50% vest as follows: 1/3 on 1/18/2024; 1/3 on 1/18/2025; and 1/3 on 1/18/2026.